PLK1 and neoplasm: Different targetable kinases associated to mitosis were up-regulated in bone metastases, including PLK1, AURKA, AURKB, CDK1 and MPS1. Importantly, we found that four out of seven PDX models responded dramatically (with complete response or tumour regression) to the PLK1 inhibitor volasertib.